Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin Genetics Inks $1.2M Research Agreement with ABG

NEW YORK (GenomeWeb News) — Interleukin Genetics has signed a $1.2 million research agreement with Alticor subsidiary Access Business Group International to search for genetic variations in four main disease areas: osteoporosis, cardiovascular disease, nutrigenomics, and dermagenomics.
Under the terms of the agreement, Interleukin will conduct studies to correlate SNPs with the risk of osteoporosis or cardiovascular disease in Asian populations, and will also conduct additional studies in North American populations to identify genetic factors that influence skin appearance and athletic performance in response to nutritional products.
The company said that around $800,000 of unspent funding from earlier research pacts with Alticor will be credited against the costs of the ABG agreement.
This is the eighth research agreement between Interleukin Genetics and Alticor. Earlier agreements led to the commercialization of a proprietary genetic test for the risk of early heart disease, a nutritional supplement for those testing positive for the heart risk factor, as well as a general nutrition test panel.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.